Bright Health Group
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Bright Health Group generated cash of -$2,726,546,000, which is less than the previous year. Cash used in financing activities reached the amount of $49,906,000 last year. Net change in cash is therefore -$1,557,010,000.
Cash Flow
| 2018 | -27.03M | -6.94M | 203.05M |
|---|---|---|---|
| 2019 | -8.20M | -94.64M | 424.06M |
| 2020 | -57.23M | -689.74M | 712.44M |
| 2021 | 82.05M | -552.89M | 1.04B |
| 2022 | 234.49M | -429.72M | 1.06B |
| 2023 | -2.72B | 1.11B | 49.90M |
BHG Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 1.93B | 1.06B | 488.37M | 522.91M | 201.70M | 32.61M |
Operating activities | ||||||
Net income | -1.26B | -1.35B | -1.18B | -248.44M | -125.33M | -62.64M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 24.16M | 50.57M | 35.48M | 8.28M | 1.13M | 1.03M |
Stock-based compensation expense | 83.69M | 109.71M | 68.42M | 5.45M | 1.86M | 257K |
| Deferred income tax benefit | 83.69M | 109.71M | 68.42M | 5.45M | 1.86M | 257K |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | -7.75M | 28.78M | -32.94M | 24.63M | -201K | -568K |
Inventories | 0 | 0 | 1.07B | 34.53M | 83.17M | 13.43M |
Accounts payable | -149.32M | 2.72M | 192.61M | 97.01M | 25.55M | 17.94M |
Cash generated by operating activities | -2.72B | 234.49M | 82.05M | -57.23M | -8.20M | -27.03M |
Investing activities | ||||||
Purchases Of Investments | -837.07M | -1.45B | -1.01B | -916.82M | -300.32M | -166.81M |
Investments In Property Plant And Equipment | -2.89M | -27.44M | -30.41M | -6.47M | -793K | -694K |
Acquisitions Net | 0 | -310K | -431.79M | -230.33M | -31.85M | 0 |
Cash generated by investing activities | 1.11B | -429.72M | -552.89M | -689.74M | -94.64M | -6.94M |
Financing activities | ||||||
Common Stock Issued | 0 | 1.31M | 898.71M | 1.24M | 260K | 57K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -200M | 0 | 0 | 0 |
Cash used in financing activities | 49.90M | 1.06B | 1.04B | 712.44M | 424.06M | 203.05M |
Net Change In Cash | -1.55B | 871.14M | 572.80M | -34.53M | 321.20M | 169.08M |
Cash at end of period | 375.28M | 1.93B | 1.06B | 488.37M | 522.91M | 201.70M |
| Data source | Data source | Data source |